
Medgensys Laboratories Private Limited
About Medgensys Laboratories Private Limited
Data last updated:
Medgensys Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2006PTC156151. Its GSTIN is 07AAECM9159R1ZJ (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Medgensys Chempharm (India) Private Limited. It is led by directors Vijender Kumar and Archana Maggu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 78 Greater Kailash – I, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.69 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.09 Cr (net margin 56.7%) and EBITDA of ₹3 Cr (EBITDA margin 81.3%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 40% over five years.
As per MCA filings, the company has open charges of ₹78.2 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medgensys Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 78 Greater Kailash – I, New Delhi, Delhi, India – 110048
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medgensys Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medgensys Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medgensys Laboratories Private Limited, buy the company report.
Financials of Medgensys Laboratories Private Limited
FY 2025 filings availableMedgensys Laboratories Private Limited reported revenue of ₹3.69 Cr (up 213% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 213% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 40%. EBITDA rose 245% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 81.3% | ||||
| Net Profit Margin | 56.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medgensys Laboratories Private Limited, buy the company report.
Board of directors of Medgensys Laboratories Private Limited
Medgensys Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijender Kumar | Director | 04 Jul 2022 | 4 Years 4 Months | Current |
| Archana Maggu Also directs: Pleasantville Investments Private Limited | Director | 15 May 2015 | 11 Years 5 Months | Current |
Auditor
Medgensys Laboratories Private Limited is audited by SUNIL DHAWAN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL DHAWAN & ASSOCIATES | FY 2023 | 006645N |
Shareholding
The shareholding of Medgensys Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medgensys Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2020 | 100421980 | Hdfc Bank Limited | ₹78.2 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Medgensys Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Court case (TRAFFIC) | Filed against the company by State of Haryana | Disposed |
To see the full case history of Medgensys Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Medgensys Laboratories Private Limited has 18 MSME Form 1 returns on record between 2016 and 2021, listing 91 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SRP Logistics Private Limited | |||
| Lee Pharma Limited | |||
| Apex Healthcare Limited | |||
| Rakshit Pharmaceuticals Limited |
To see the full MSME payment records of Medgensys Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medgensys Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECM9159R1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medgensys Laboratories Private Limited, buy the company report.
Recent activity
Medgensys Laboratories Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Vijender Kumar ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Medgensys Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 December 2006 (20+ years old) and is registered under CIN U24110DL2006PTC156151.
Medgensys Laboratories has 2 current directors:
- Vijender Kumar - Director
- Archana Maggu - Director
The latest financial statements of Medgensys Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medgensys Laboratories is 07AAECM9159R1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Medgensys Laboratories is U24110DL2006PTC156151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medgensys Laboratories has 1 court case on record: 1 filed against it.
Medgensys Laboratories was incorporated on 04 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Vijender Kumar ceased to be Additional Director on 30 Sep 2022. Rajesh Maggu ceased to be Director on 12 Jul 2022. Vijender Kumar was appointed as Director on 04 Jul 2022. Medgensys Laboratories has 6 board changes on record in total.
Medgensys Laboratories has 18 MSME Form 1 returns on record between 2016 and 2021, listing 91 overdue payments to 4 micro and small suppliers. The latest return was filed on 26 Mar 2022.
The registered office of Medgensys Laboratories is at S – 78 Greater Kailash – I, New Delhi, Delhi, India – 110048.
Medgensys Laboratories operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

